FDA Investigator Michael P Anthony
Michael P Anthony has conducted inspections on 63 sites in 3 countries as of 11 Nov 2019. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
63
Last Inspection Date:
11 Nov 2019
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India,
Mexico
FDA Investigators that have inspected at least one site in common with Michael P Anthony:
Alan R Condon,
Althea A Williams,
Amber G Wardwell,
Andrew M Barlow,
Anthony W Thomas,
Arie C Menachem,
Asia D Clark,
Barbara D Wright,
Bonita S Chester,
Brenda P King,
Byungja E Marciante,
Charles Yuanchia Kuo, PhD,
Christopher Janik,
Clotia Cabbey Mensah,
Constance Desimone,
Craig A Garmendia,
Daniel L Aisen,
Darin S Wiegers,
David P Vanhouten,
Dell S Moller,
Diane C Thibodeau,
Diane M Prince,
Dien N Nguyen,
Dolores Harper,
Donna J Clevenger,
Edmund F Mrak, Jr,
Edward J Janik,
Elizabeth B Griffin,
Ellen P Madigan,
Eric C Schmitt,
Frank P Hurst,
Gary J Hagan,
Geoffrey K Kilili,
Haley H Seymour,
Hasan A Irier, PhD,
James H Tanner,
Janete F Guardia,
Jeanne J Thai,
John A Sciacchitano,
John L Zaccone,
John P Mistler,
John S Hartford,
Jonathan G Matrisciano,
Jose A Torres,
Justine M Corson,
Kara A Scheibner, PhD,
Karen M Cooper,
Karen Mcnabb Noon,
Katherine D Adams,
Kent A Conforti,
Lauren Iacono Connors, PhD,
Laurie B Frazier,
LCDR Debra Emerson,
Leo B Zadecky,
Li Hongpaul Yeh, PhD,
Linda R Kuchenthal,
Lori A Gioia,
Lucie Yang,
Makini Cobourne Duval, PhD,
Margaret M Sands,
Mary Jeanet Mcgarry,
Matthew C Watson,
Maura Rooney,
Megan A Haggerty,
Melkamu Getie Kebtie, PhD,
Meredith L Miller,
Michael P Sweeney,
Michael Serrano,
Michelle M Noe Varga,
Monique C Lo,
Nancy A Bellamy,
Nealie C Newberger,
Paraluman S Leonin,
Paul P Geraci,
Rachael O Oyewole,
Ramon E Martinez,
Richard W Berning,
Robert J Martin,
Robert O'brian,
Ronda Rloyd Jones,
Rory K Geyer,
Sandra P White,
Sara M Onyango,
Sara M Richardson,
Scott B Laufenberg,
Scott C Lute,
Sharon K Thoma, PharmD,
Sripal R Mada, PhD,
Stephen C Smith,
Sunita Pandey,
Susan Leibenhaut, MD,
Susanne M Richardson, MS RAC,
Thomas J Arista,
Thomas Siebertz,
Tina A Desorcy,
Victoria D'addeo,
Victoria M Daddeo,
Wayne E Seifert,
Young M Choi, PhD
Michael P Anthony's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2018 | EIR | Agios Pharmaceuticals, INC. - EIR, 2018-03-09 |
August, 2019 | FDA 483 | Fresenius Medical Care Holdings, Inc. - Form 483, 2019-08-02 |
December, 2015 | FDA 483 | Elliott Israel, M.D. - Form 483, 2015-12-18 |
February, 2018 | EIR | Richard Stone, MD - EIR, 2018-02-20 |
December, 2015 | EIR | Perceptive Informatics LLC (d.b.a. Calyx) - EIR, 2015-12-03 |
July, 2018 | FDA 483 | Shire Human Genetic Therapies, Inc. - Form 483, 2018-07-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more